BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25953827)

  • 21. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.
    Nanba K; Tsuiki M; Sawai K; Mukai K; Nishimoto K; Usui T; Tagami T; Okuno H; Yamamoto T; Shimatsu A; Katabami T; Okumura A; Kawa G; Tanabe A; Naruse M
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1567-74. PubMed ID: 23443813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients.
    Rossi GP; Ganzaroli C; Miotto D; De Toni R; Palumbo G; Feltrin GP; Mantero F; Pessina AC
    J Hypertens; 2006 Feb; 24(2):371-9. PubMed ID: 16508586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas.
    Saner-Amigh K; Mayhew BA; Mantero F; Schiavi F; White PC; Rao CV; Rainey WE
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1136-42. PubMed ID: 16332935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma.
    Fu B; Zhang X; Wang GX; Lang B; Ma X; Li HZ; Wang BJ; Shi TP; Ai X; Zhou HX; Zheng T
    J Urol; 2011 May; 185(5):1578-82. PubMed ID: 21419437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and treatment of patients with benign formations of the adrenal cortex].
    Podluzhnyĭ AA
    Klin Khir; 2013 Nov; (11):57-60. PubMed ID: 24501992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
    Lin YH; Wu XM; Lee HH; Lee JK; Liu YC; Chang HW; Lin CY; Wu VC; Chueh SC; Lin LC; Lo MT; Ho YL; Wu KD;
    J Hypertens; 2012 Aug; 30(8):1606-13. PubMed ID: 22688266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
    Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
    Boulkroun S; Samson-Couterie B; Dzib JF; Lefebvre H; Louiset E; Amar L; Plouin PF; Lalli E; Jeunemaitre X; Benecke A; Meatchi T; Zennaro MC
    Hypertension; 2010 Nov; 56(5):885-92. PubMed ID: 20937967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas.
    Howard B; Wang Y; Xekouki P; Faucz FR; Jain M; Zhang L; Meltzer PG; Stratakis CA; Kebebew E
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E536-43. PubMed ID: 24423307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
    Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypomethylation associated vitamin D receptor expression in ATP1A1 mutant aldosterone-producing adenoma.
    Nanao Y; Oki K; Kobuke K; Itcho K; Baba R; Kodama T; Otagaki Y; Okada A; Yoshii Y; Nagano G; Ohno H; Arihiro K; Gomez-Sanchez CE; Hattori N; Yoneda M
    Mol Cell Endocrinol; 2022 May; 548():111613. PubMed ID: 35257799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of aldosterone-producing adrenal adenomas--does adrenalectomy increase costs?
    Reimel B; Zanocco K; Russo MJ; Zarnegar R; Clark OH; Allendorf JD; Chabot JA; Duh QY; Lee JA; Sturgeon C
    Surgery; 2010 Dec; 148(6):1178-85; discussion 1185. PubMed ID: 21134549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
    Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
    Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of primary aldosteronism: from screening to subtype differentiation.
    Mulatero P; Dluhy RG; Giacchetti G; Boscaro M; Veglio F; Stewart PM
    Trends Endocrinol Metab; 2005 Apr; 16(3):114-9. PubMed ID: 15808809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in CYP11B1 gene converting 11beta-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomas.
    Pilon C; Mulatero P; Barzon L; Veglio F; Garrone C; Boscaro M; Sonino N; Fallo F
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4228-31. PubMed ID: 10566677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the renin gene in patients with aldosterone-producing adenomas by polymerase chain reaction-single stranded conformational polymorphisms and long polymerase chain reaction.
    Ballantine DM; Klemm SA; Tunny TJ; Stowasser M; Gordon RD
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):484-6. PubMed ID: 8582111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary aldosteronism: experience with thirty-eight patients.
    Herwig KR
    Surgery; 1979 Sep; 86(3):470-4. PubMed ID: 473033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and loss of the insertion allele in aldosterone-producing adenoma.
    Tunny TJ; Xu L; Richardson KA; Stowasser M; Gartside M; Gordon RD
    J Hum Hypertens; 1996 Dec; 10(12):827-30. PubMed ID: 9140790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a role for segmental adrenal venous sampling and adrenal sparing surgery in patients with primary aldosteronism?
    Satoh F; Morimoto R; Seiji K; Satani N; Ota H; Iwakura Y; Ono Y; Kudo M; Nezu M; Omata K; Tezuka Y; Kawasaki Y; Ishidoya S; Arai Y; Takase K; Nakamura Y; McNamara K; Sasano H; Ito S
    Eur J Endocrinol; 2015 Oct; 173(4):465-77. PubMed ID: 26194502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary hyperaldosteronism (Conn syndrome): MR imaging findings.
    Sohaib SA; Peppercorn PD; Allan C; Monson JP; Grossman AB; Besser GM; Reznek RH
    Radiology; 2000 Feb; 214(2):527-31. PubMed ID: 10671606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.